Mar-08-21 Upgrade
Raymond James
Mkt Perform → Outperform
$166
Mar-08-21 Upgrade
BofA Securities
Neutral → Buy
$180
Sep-21-20 Initiated
Atlantic Equities
Overweight
$191
Aug-14-20 Upgrade
Edward Jones
Hold → Buy
Aug-12-20 Downgrade
Gabelli & Co
Buy → Hold
May-27-20 Initiated
Jefferies
Buy
$152
Jan-10-20 Initiated
Raymond James
Mkt Perform
Sep-09-19 Initiated
Goldman
Buy
$145
Jul-01-19 Downgrade
BofA/Merrill
Buy → Neutral
$111 → $120
Jun-11-19 Initiated
Barclays
Overweight
$120
May-23-19 Initiated
Guggenheim
Buy
$114
May-03-19 Downgrade
Gabelli & Co
Buy → Hold
$108
Mar-20-19 Initiated
SunTrust
Hold
Mar-04-19 Upgrade
Stifel
Hold → Buy
$97 → $110
Jan-23-19 Initiated
UBS
Neutral
$86
Oct-15-18 Upgrade
JP Morgan
Neutral → Overweight
Aug-22-18 Downgrade
Stifel
Buy → Hold
$95
Aug-03-18 Reiterated
Stifel
Buy
$86 → $95
Apr-19-18 Reiterated
Citigroup
Buy
$85 → $98
Mar-19-18 Downgrade
Morgan Stanley
Overweight → Equal-Weight
Apr-16-21 07:14AM
Apr-13-21 09:39AM
08:59AM
Apr-01-21 06:25AM
Mar-31-21 08:30AM
07:59AM
Mar-30-21 04:51PM
Mar-26-21 09:53AM
Mar-24-21 08:58AM
Mar-21-21 10:28AM
Mar-18-21 11:30AM
Mar-17-21 11:40AM
Mar-16-21 08:08AM
07:32AM
Mar-15-21 09:22AM
Mar-13-21 09:34AM
07:54AM
Mar-11-21 02:24PM
Mar-10-21 08:30AM
Mar-09-21 07:57AM
Mar-08-21 01:00PM
10:04AM
09:51AM
08:31AM
Mar-01-21 11:40AM
Feb-24-21 08:30AM
Feb-22-21 09:51AM
08:30AM
03:00AM
Feb-17-21 10:08AM
08:57AM
Feb-16-21 04:30PM
04:20PM Investor's Business Daily
08:41AM
08:09AM Investor's Business Daily
07:00AM
Feb-15-21 10:28AM
Feb-12-21 08:38AM
Feb-11-21 12:10PM
09:35AM
Feb-10-21 05:14PM
Feb-09-21 12:30PM
11:07AM
Feb-03-21 11:40AM
Jan-29-21 06:35AM
Jan-28-21 10:00AM
Jan-22-21 09:37AM
Jan-14-21 08:21AM
Jan-12-21 11:40AM
Dec-30-20 08:30AM
Dec-24-20 06:54AM
Dec-23-20 10:59AM
Dec-18-20 08:30AM
Dec-15-20 10:55AM
Dec-09-20 04:30PM
Dec-08-20 04:30PM
Dec-07-20 10:21AM
Dec-05-20 11:32AM
Dec-01-20 03:48PM
09:35AM
Nov-16-20 08:00AM
Nov-13-20 09:54AM
09:42AM
Nov-12-20 08:00AM
Nov-09-20 02:52PM
Nov-06-20 10:30PM
04:35PM Investor's Business Daily
01:39PM
09:59AM
Nov-05-20 04:13PM Investor's Business Daily
11:38AM
10:39AM
08:58AM
08:25AM
07:00AM
03:00AM Investor's Business Daily
Nov-04-20 08:42AM
08:25AM
Nov-03-20 10:40AM
Nov-02-20 10:43AM
Oct-30-20 12:57PM
Oct-28-20 11:40AM
Oct-26-20 02:08PM
08:30AM
Oct-23-20 04:06PM
Oct-21-20 12:03PM
Oct-16-20 11:30AM
Oct-14-20 12:10PM
09:01AM
Oct-07-20 04:33PM
Oct-05-20 11:40AM
Sep-30-20 08:30AM
Sep-23-20 02:10PM
Sep-17-20 11:40AM
Sep-15-20 08:00PM
06:14PM
10:40AM
Sep-13-20 08:00PM
Sep-11-20 09:04AM
Sep-10-20 08:30AM
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides other pharmaceutical products, which comprise pain and sedation, antiemetic, reproductive, and oncology products; Dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives that offer medicines to livestock. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision livestock farming. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Kelly Robert Edward Executive Vice President Mar 01 Option Exercise 28.30 1,550 43,865 11,365 Mar 03 04:25 PM Kelly Robert Edward Executive Vice President Mar 01 Sale 156.11 2,055 320,806 9,310 Mar 03 04:25 PM PECK KRISTIN C Chief Executive Officer Feb 25 Option Exercise 30.89 12,000 370,680 50,351 Mar 01 04:19 PM PECK KRISTIN C Chief Executive Officer Feb 25 Sale 158.37 16,427 2,601,476 33,924 Mar 01 04:19 PM Alaix Juan Ramon Director Feb 19 Option Exercise 73.24 133,070 9,746,047 347,377 Feb 23 04:59 PM Lagano Roxanne Executive Vice President Feb 19 Option Exercise 41.83 6,000 250,980 48,083 Feb 22 04:32 PM SCULLY ROBERT W Director Feb 19 Buy 164.68 7,590 1,249,931 7,590 Feb 23 06:47 PM Lagano Roxanne Executive Vice President Feb 19 Sale 167.88 6,000 1,007,280 42,083 Feb 22 04:32 PM Alaix Juan Ramon Director Feb 19 Sale 160.55 133,070 21,363,973 214,307 Feb 23 04:59 PM Chen Heidi C. Executive Vice President Feb 18 Option Exercise 55.02 600 33,012 25,245 Feb 22 04:31 PM Chen Heidi C. Executive Vice President Feb 18 Sale 170.04 600 102,024 24,645 Feb 22 04:31 PM Trawicki Roman Executive Vice President Feb 17 Option Exercise 73.24 3,285 240,593 8,114 Feb 18 04:54 PM Trawicki Roman Executive Vice President Feb 17 Sale 165.82 4,491 744,698 3,623 Feb 18 04:54 PM David Glenn Chief Financial Officer Feb 16 Option Exercise 73.24 26,285 1,925,113 59,186 Feb 18 04:56 PM David Glenn Chief Financial Officer Feb 16 Sale 168.92 26,285 4,439,965 32,901 Feb 18 04:56 PM Kelly Robert Edward Executive Vice President Feb 11 Option Exercise 28.30 1,550 43,865 10,758 Feb 16 05:16 PM Kelly Robert Edward Executive Vice President Feb 11 Sale 161.15 2,054 331,002 8,704 Feb 16 05:16 PM Chen Heidi C. Executive Vice President Dec 01 Option Exercise 41.83 1,180 49,359 17,515 Dec 03 05:16 PM Chen Heidi C. Executive Vice President Dec 01 Sale 161.64 1,180 190,735 16,335 Dec 03 05:16 PM PECK KRISTIN C Chief Executive Officer Nov 25 Option Exercise 30.89 6,500 200,785 38,374 Nov 25 04:42 PM PECK KRISTIN C Chief Executive Officer Nov 25 Sale 161.51 10,500 1,695,810 27,874 Nov 25 04:42 PM Lagano Roxanne Executive Vice President Nov 19 Option Exercise 41.83 6,000 250,980 41,680 Nov 20 04:47 PM Lagano Roxanne Executive Vice President Nov 19 Sale 164.06 6,000 984,360 35,680 Nov 20 04:47 PM Alaix Juan Ramon Director Nov 13 Sale 165.46 91,747 15,180,561 4,266 Nov 17 04:30 PM Chen Heidi C. Executive Vice President Nov 02 Option Exercise 41.83 1,179 49,318 17,514 Nov 03 04:47 PM Chen Heidi C. Executive Vice President Nov 02 Sale 161.43 1,179 190,326 16,335 Nov 03 04:47 PM Chen Heidi C. Executive Vice President Oct 01 Option Exercise 41.83 1,179 49,318 17,514 Oct 02 06:04 PM Trawicki Roman Executive Vice President Oct 01 Option Exercise 55.02 4,080 224,482 5,501 Oct 02 06:08 PM Trawicki Roman Executive Vice President Oct 01 Sale 166.03 5,501 913,353 0 Oct 02 06:08 PM Chen Heidi C. Executive Vice President Oct 01 Sale 166.23 1,179 195,985 16,335 Oct 02 06:04 PM Rhodes Linda Director Sep 04 Sale 159.16 1,087 173,007 1,468 Sep 08 04:18 PM Chen Heidi C. Executive Vice President Sep 01 Option Exercise 41.83 1,179 49,318 17,514 Sep 02 04:48 PM Chen Heidi C. Executive Vice President Sep 01 Sale 160.71 1,179 189,477 16,335 Sep 02 04:48 PM PECK KRISTIN C Chief Executive Officer Aug 25 Option Exercise 30.89 6,500 200,785 42,374 Aug 26 06:00 PM PECK KRISTIN C Chief Executive Officer Aug 25 Sale 157.61 10,500 1,654,889 31,874 Aug 26 06:00 PM Lagano Roxanne Executive Vice President Aug 19 Option Exercise 41.83 6,000 250,980 41,680 Aug 21 04:27 PM Lagano Roxanne Executive Vice President Aug 19 Sale 160.37 6,000 962,220 35,680 Aug 21 04:27 PM Reed Willie M Director Aug 13 Sale 159.07 1,885 299,847 4,635 Aug 17 04:23 PM Knupp Catherine A. Executive Vice President Aug 13 Sale 158.86 13,000 2,065,160 50,368 Aug 17 04:26 PM Chen Heidi C. Executive Vice President Aug 03 Option Exercise 41.83 1,179 49,318 17,514 Aug 04 04:31 PM Chen Heidi C. Executive Vice President Aug 03 Sale 152.19 1,179 179,432 16,335 Aug 04 04:31 PM Chen Heidi C. Executive Vice President Jul 01 Option Exercise 41.83 1,179 49,318 17,514 Jul 02 06:13 PM Trawicki Roman Executive Vice President Jul 01 Option Exercise 55.02 4,079 224,427 6,920 Jul 02 06:18 PM Trawicki Roman Executive Vice President Jul 01 Sale 137.29 5,499 754,958 1,421 Jul 02 06:18 PM Chen Heidi C. Executive Vice President Jul 01 Sale 137.29 1,179 161,865 16,335 Jul 02 06:13 PM Chen Heidi C. Executive Vice President Jun 01 Option Exercise 41.83 1,179 49,318 17,514 Jun 02 04:18 PM Chen Heidi C. Executive Vice President Jun 01 Sale 138.65 1,179 163,468 16,335 Jun 02 04:18 PM PECK KRISTIN C Chief Executive Officer May 26 Option Exercise 27.97 6,500 181,787 46,374 May 28 04:29 PM PECK KRISTIN C Chief Executive Officer May 26 Sale 131.31 10,500 1,378,783 35,874 May 28 04:29 PM Lagano Roxanne Executive Vice President May 19 Option Exercise 46.09 4,463 205,700 40,143 May 21 04:19 PM Lagano Roxanne Executive Vice President May 19 Sale 131.02 4,463 584,742 35,680 May 21 04:19 PM Chen Heidi C. Executive Vice President May 01 Option Exercise 41.83 1,179 49,318 17,514 May 04 04:49 PM Chen Heidi C. Executive Vice President May 01 Sale 127.44 1,179 150,252 16,335 May 04 04:49 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite